NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric
A rubric for evaluating the FAIRness of NIH-CFDE Resources
Tags: nihcommonfund
URL(s):
View AssociationsRubric Assessments (626384)
| Assessment | Metrics | Date | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Target | Project | Contact information is provided for the creator(s) of the dataset. | Globally unique identifier | Machine-readable metadata | Standardized metadata | Resource identifier in metadata | Open, Free, Standardized Access protocol | Digital resource license | Metadata license | NIH program name is available for querying | NIH project name is available for querying | The institution that created this dataset is available | A biological assay is present and resolvable in CFDE-specified ontology (OBI) | A relevant anatomical part is present and resolvable in the UBERON Ontology | A relevant disease is present and resolvable in the MONDO Ontology | A relevant file type is present and resolvable in the EDAM Ontology | A relevant taxonomy is present and resolvable in the NCBITaxon Ontology | A relevant cell line is present and resolvable in the Cellosaurus Ontology | A landing page exists and is accessible | ||
| Sleep apnea and cardiovascular samples ceramide concentrations | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Diet, genetics and gut microbiome drive dynamic changes in plasma metabolites [plasma] | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Effects of NO Donor Therapy on the Dystrophic Mouse Quadricep Metabolome (part VIII) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Insights into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) phenotypes through comprehensive metabolomics (part III)) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| SCFA in Hypertension | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolomics Involved in Early Life Antibiotic Exposures(TranSTAT-Serum) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolomic profiling of IDH1 mutation (part II) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolomic profiling of influenza: a 2009 pandemic H1N1 influenza in lean and obese mice (via blood and tissue) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Pharmacometabolomics of L-Carnitine Treatment Response Phenotypes in Patients with Septic Shock | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Changes in metabolites and lipid mediators associated with supervised exercise training for peripheral | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Global Nonhuman primate (NHP) urine metabolomics (part-I) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Sleep apnea and cardiovascular samples nueromodulators panel | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Impact of recurrent hypoglycemia on brain metabolite profile | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Untargeted metabolomic profile of reciprocal hemizygotes (oak/win hybrid, genes AUA1, ARG82) (part III) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Identifying metabolic adaptations characteristic of multiple myeloma cells via mass spectrometry-based metabolite profiling from Bone Marrow Plasma | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Pilot experiment looking for the existence of certain molecules in pancreatic cancer cells | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| THP1 Human Monocyte cells Project A (part I) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Exahustive degradation of nucleotide triphosphates | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Effect of genetic lesions on glioblastoma (NP, NPA, NPAI, NS) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Role of medium in bacterial growth | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Primary T Cell Baseline (Donor 5) - II | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Mechanism Behind Stay Green Trait in Bread Wheat (Triticum aestivum L.) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Identifying metabolic adaptations characteristic of multiple myeloma cells via targeted sphingolipids concentrations from bone marrow and peripheral plasma | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| NIST lipidomics intralaboratory study | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
